References
- Radomski L, Park G D, Goldberg M J, Spector R, Johnson G F, Quee CK. Model for theophylline overdose treatment with oral activated charcoal. Clin Pharmacol Ther 1984; 35: 402–408
- Sintek C, Hendeles L, Weinberger M. Inhibition of theophylline absorption by activated charcoal. J Pediatr 1979; 94: 314–316
- Swartz C M, Sherman A. The treatment of tricyclic anti-depressant overdose with repeated activated charcoal. J Clin Psychopharmacol 1984; 4: 336–340
- Lalonde R L, Deshpande R, Hamilton P P, McLeon W M, Greenway DC. Acceleration of digoxin clearance by activated charcoal. Clin Pharmacol Ther 1985; 37: 367–371
- Neuvonen P J, Elonen E. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man. Eur J Clin Pharmacol 1980; 17: 51–57
- Berg M J, Berlinger W G, Goldberg M J, Spector R, Johnson GF. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med 1982; 307: 642–644
- Reissell P, Manninen V. Effect of administration of activated charcoal and fiber on absorption, excretion and steady blood levels of digoxin and digitoxin: Evidence for intestinal secretion of the glycosides. Acta Med Scand 1982; 668: 88–90
- Shannon M, Amitai Y, Lovejoy FH. Multiple dose activated charcoal for theophylline poisoning in young infants. Pediatrics 1987; 80: 368–370
- Roberts RJ. Drug Therapy in Infants. WB Saunders and Company, Philadelphia 1984; 97–104